Skip to main content
SpringerLink
Log in

Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer’s disease: The Alzhemedtm (Tramiprosate) experience

  • The Alzhemed™ (Tramiprosate) Experience
  • Published:
JNHA - The Journal of Nutrition, Health and Aging

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gandy S. The role of cerebral amyloid accumulation in common forms of Alzheimer disease. Journal of Clinical Investigation. 2005; 115: 1121–1129.

    PubMed  CAS  Google Scholar 

  2. Caniveri L, Abramov A, & Duchen MR. Toxicity of amyloid B peptide: Tales of calcium, mitochondria, and oxidative stress. Neurochemical Research, 2004; 29: 637–650.

    Article  Google Scholar 

  3. Sampaio C. Alzheimer’s disease: Disease modifying trials. Where are we? Where do we need to go? A reflective paper. Journal of Nutrition, Health and Aging. 2006; 10(2): 113–115.

    CAS  Google Scholar 

  4. Katz R. Biomarkers and Surrogate Markers: An FDA perspective. NeuroRx. 2004; 1: 189–195.

    Article  PubMed  Google Scholar 

  5. Goshe KM, Mortimer JA, Smith CD, et al. Hippocampal volume as an index of Azheimer neuropathology: findings from the Nun study. Neurology. 2002; 58: 1476–1482

    Google Scholar 

  6. Haroutunian V, Perl, DP, Purohit, DP, et al. Regional distribution of neuritic plaques in the non-demented elderly and subjects with very mild Alzheimer disease. Archives of Neurology. 1998; 1185–1191.

  7. Convit A, de Leon MJ, Golomb J, et al. Hippocampal atrophy in early Alzheimer’s disease: anatomic specificity and validation. Psychiatric Quarterly. 1993; 64: 371–387.

    Article  PubMed  CAS  Google Scholar 

  8. Csernansky JG, Wang L, Joshi S. et al. Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Neurology. 2000; 55: 1636–1643.

    PubMed  CAS  Google Scholar 

  9. Dickerson BC, Goncharova I, Sullivan MP, et al. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease. Neurobiology of Aging. 2001; 22: 747–754.

    Article  PubMed  CAS  Google Scholar 

  10. Du AT, Schuff N, Amend D. et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer’s disease. Journal of Neurology, Neurosurgery and Psychiatry. 2001; 71: 441–447.

    Article  CAS  Google Scholar 

  11. Du AT, Schuff N, Kramer JH et al. Higher Atrophy Rate of Entorhinal Cortex than Hippocampus in AD. Neurology. 2004; 62: 422–427.

    PubMed  CAS  Google Scholar 

  12. Krasuski JS, Alexander GE, Horwitz B. et al. Relation of medial temporal lobe volumes to age and memory function in non-demented adults with Down’s syndrome: implications for the prodromal phase of Alzheimer’s disease. American Journal of Psychiatry. 2002; 159: 74–81.

    Article  PubMed  Google Scholar 

  13. Mega MS, Small, GW, Xu ML, et al. Hippocampal atrophy in persons with age-associated memory impairment: volumetry within a common space. Psychosomatic Medicine. 2002; 64; 487–492.

    PubMed  Google Scholar 

  14. Mu Q, Xie J, Wen Z, et al. A quantitative MR study of the hippocampal formation, the amygdale, and the temporal horn of the lateral ventricle in healthy subjects 40 to 90 years of age. American Journal of Neuroradiology. 1999; 20: 207–211.

    PubMed  CAS  Google Scholar 

  15. Xu Y, Jack CRJ, O’Brien PC, et al. Usefulness of MRI measures of entrorhinal versus hippocampus in AD. Neurology. 2000; 14: 531–545.

    Google Scholar 

  16. Gervais F, Paquette J, Morissette C, et al. Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis. Neurobiology of Aging. 2007; 28: 537–547.

    Article  PubMed  CAS  Google Scholar 

  17. Azzi M, Morissette C, Fallon L, et al. Involvement of both GABA-dependent and - independent pathways in tramiprosate neuroprotective effects against amyloid-beta toxicity. 8th International Conference AD/PD, Salzburg, Austria, March 14–18. 2007.

  18. Aisen P, Saumier D, Briand R, et al. A Phase II study targeting amyloid- with 3APS in mild-to-moderate Alzheimer disease. Neurology. 2006; 67: 1757–1763.

    Article  PubMed  CAS  Google Scholar 

  19. Hsu YY, Schuff N, Du AT, et al, Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia. Journal of Magnetic Reson ance Imaging. 2002; 16:305–310.

    Article  Google Scholar 

  20. Thal LJ, Kantarci K, Reiman EM, et al. The role of biomarkers in clinical trials for Alzheimer disease. Alzheimer Disease and Associated Disorders. 2006; 20: 6–15

    Article  PubMed  Google Scholar 

  21. Stern RG, Mohs RC, Davidson M, et al. A longitudinal study of Alzheimer’s disease: measurement, rate, and predictors of cognitive deterioration. American Journal of Psychiatry. 1994; 151: 390–396.

    PubMed  CAS  Google Scholar 

  22. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurology. 2007; 6: 734–746.

    Article  PubMed  Google Scholar 

  23. Laakso MP, Soininen H, Partanen K, et al. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer’s disease: correlation with memory functions. Journal of Neural Transmission. Parkinson’s Disease and Dementia Section. 1995; 9: 73–86.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. BELLUS Health Inc., 275 boul. Armand-Frappier, Laval, Quebec, H7V 4A7, Canada

    D. Saumier & A. Duong

  2. University of California, San Diego, 9500 Gilman Drive M/C 0949, La Jolla, CA, 92093, USA

    P. S. Aisen

  3. McGill Ctr / Studies in Aging, 6825 Lasalle Blvd, Verdun, QC, H4H 1R3, Canada

    S. Gauthier

  4. Gérontopole, Pôle Gériatrie, Centre Hospitalier Universitaire, Alzheimer Disease Research and Clinical Center, University of Toulouse, INSERM U.558, Toulouse, France

    B. Vellas

  5. New York University School of Medicine, 550 First Avenue, New York, NY, 10016, USA

    S. H. Ferris

  6. Nathan Kline Institute, Orangeburg, NY, 10962, USA

    S. H. Ferris

  7. Synarc Inc., 575 Market Street, 17th Floor, San Francisco, CA, 94105, USA

    J. Suhy, J. Oh & W. Lau

  8. OVOS Natural Health Inc., 275 boul. Armand-Frappier, Laval, Quebec, H7V 4A7, Canada

    D. Garceau

  9. JSS Medical Research, 4492 St-Catherine Street West, Westmount, Quebec, H3Z 1R7, Canada

    D. Haine

  10. Division of Clinical Epidemiology, McGill University, Research Institute of the McGill University Health Centre, Royal Victoria Hospital, V Building, 687 Pine Avenue West, Montreal, Quebec, H3A 1A1, Canada

    J. Sampalis

Authors
  1. D. Saumier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. S. Aisen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Gauthier
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Vellas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. H. Ferris
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Duong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. Suhy
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. W. Lau
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. D. Garceau
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. D. Haine
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. J. Sampalis
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saumier, D., Aisen, P.S., Gauthier, S. et al. Lessons learned in the use of volumetric MRI in therapeutic trials in Alzheimer’s disease: The Alzhemedtm (Tramiprosate) experience. J Nutr Health Aging 13, 370–372 (2009). https://doi.org/10.1007/s12603-009-0047-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12603-009-0047-4

Keywords

Search

Navigation